As a result, PP2A and Pin1 are recognized as crucial factors that have the potential to inhibit or reverse the hyperphosphorylation and aggregation of Tau, offering promising insights into the understanding of AD and related disorders. The gene discussed is MAPT; the disease is Alzheimer disease.